Order Article Reprints

Koike H, Nishida Y, Shinomura T, Ohkawara B, Ohno K, Zhuo L, Kimata K, Ushida T, Imagama S. Possible Repositioning of an Oral Anti-Osteoporotic Drug, Ipriflavone, for Treatment of Inflammatory Arthritis via Inhibitory Activity of KIAA1199, a Novel Potent Hyaluronidase. International Journal of Molecular Sciences. 2022; 23(8):4089. https://doi.org/10.3390/ijms23084089

Koike, Hiroshi, Yoshihiro Nishida, Tamayuki Shinomura, Bisei Ohkawara, Kinji Ohno, Lisheng Zhuo, Koji Kimata, Takahiro Ushida, and Shiro Imagama. 2022. "Possible Repositioning of an Oral Anti-Osteoporotic Drug, Ipriflavone, for Treatment of Inflammatory Arthritis via Inhibitory Activity of KIAA1199, a Novel Potent Hyaluronidase" International Journal of Molecular Sciences 23, no. 8: 4089. https://doi.org/10.3390/ijms23084089

Koike, H., Nishida, Y., Shinomura, T., Ohkawara, B., Ohno, K., Zhuo, L., Kimata, K., Ushida, T., & Imagama, S. (2022). Possible Repositioning of an Oral Anti-Osteoporotic Drug, Ipriflavone, for Treatment of Inflammatory Arthritis via Inhibitory Activity of KIAA1199, a Novel Potent Hyaluronidase. International Journal of Molecular Sciences, 23(8), 4089. https://doi.org/10.3390/ijms23084089